Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Jones Website

Kathryn S. Jones, Ph.D.

Selected Publications

1)  Jensen SM, Ruscetti FW, Rein A, Bertolette DC, Saucedo CJ, O'Keefe BR, Jones KS.
Differential inhibitory effects of cyanovirin-N, griffithsin, and scytovirin on entry mediated by envelopes of gammaretroviruses and deltaretroviruses.
J. Virol. 88: 2327-32, 2014.
[Journal]
2)  Kannian P, Fernandez S, Jones KS, Green PL.
Human T lymphotropic virus type 1 SU residue 195 plays a role in determining the preferential CD4+ T cell immortalization/transformation tropism.
J. Virol. 87: 9344-52, 2013.
[Journal]
3)  Pique C, Jones KS.
Pathways of cell-cell transmission of HTLV-1.
Front Microbiol. 3: 378, 2012.
[Journal]
4)  Jones KS, Lambert S, Bouttier M, Bénit L, Ruscetti FW, Hermine O, Pique C.
Molecular aspects of HTLV-1 entry: functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors.
Viruses. 3: 794-810, 2011.
[Journal]
5)  Jones KS, Green PL.
Cloaked virus slips between cells.
Nat. Med. 16: 25-27, 2010.
[Journal]
6)  Ghez D, Lepelletier Y, Jones KS, Pique C, Hermine O.
Current concepts regarding the HTLV-1 receptor complex.
Retrovirology. 7: 99, 2010.
[Journal]
7)  Van Prooyen N, Gold H, Andresen V, Schwartz O, Jones K, Ruscetti F, Lockett S, Gudla P, Venzon D, Franchini G.
Human T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission.
Proc. Natl. Acad. Sci. U.S.A. 107: 20738-43, 2010.
[Journal]
8)  Ilinskaya A, Heidecker G, Jones K.
Interaction between the HTLV-1 envelope and cellular proteins: impact on virus infection and restriction.
Future Med Chem. 2: 1651-68, 2010.
[Journal]
9)  Gordon SN, Weissman AR, Cecchinato V, Fenizia C, Ma ZM, Lee TH, Zaffiri L, Andresen V, Parks RW, Jones KS, Heraud JM, Ferrari MG, Chung HK, Venzon D, Mahieux R, Murphy EL, Jacobson S, Miller CJ, Ruscetti FW, Franchini G.
Preexisting infection with human T-cell lymphotropic virus type 2 neither exacerbates nor attenuates simian immunodeficiency virus SIVmac251 infection in macaques.
J. Virol. 84: 3043-58, 2010.
[Journal]
10)  Valeri VW, Hryniewicz A, Andresen V, Jones K, Fenizia C, Bialuk I, Chung HK, Fukumoto R, Parks RW, Ferrari MG, Nicot C, Cecchinato V, Ruscetti F, Franchini G.
Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits.
Blood. 116: 3809-17, 2010.
[Journal]
11)  Lee K, Jones KS.
The path well traveled: using mammalian retroviruses to guide research on XMRV.
Mol. Interv. 10: 20-4, 2010.
[Journal]
12)  Lambert S, Bouttier M, Vassy R, Seigneuret M, Petrow-Sadowski C, Janvier S, Heveker N, Ruscetti FW, Perret G, Jones KS, Pique C.
HTLV-1 uses HSPG and neuropilin 1 for entry by molecular mimicry of VEGF165.
Blood. 2009.
[Journal]
13)  Jones KS, Huang YK, Chevalier SA, Afonso PV, Petrow-Sadowski C, Bertolette DC, Gessain A, Ruscetti FW, Mahieux R.
The receptor complex associated with HTLV-3 Env-mediated binding and entry is distinct from, but overlaps with, the receptor complexes of HTLV-1 and HTLV-2.
J. Virol. 2009.
[Journal]
14)  Jones KS, Petrow-Sadowski C, Huang YK, Bertolette DC, Ruscetti FW.
Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells.
Nat. Med. 14: 429-36, 2008.
[Journal]
15)  Takenouchi N, Jones KS, Lisinski I, Fugo K, Yao K, Cushman SW, Ruscetti FW, Jacobson S.
GLUT1 Is Not the Primary Binding Receptor but Is Associated with Cell-to-Cell Transmission of Human T-Cell Leukemia Virus Type 1.
J. Virol. 81: 1506-10, 2007.
[Journal]
16)  Jones KS, Fugo K, Petrow-Sadowski C, Huang Y, Bertolette DC, Lisinski I, Cushman SW, Jacobson S, Ruscetti FW.
Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells.
J. Virol. 80: 8291-302, 2006.
[Journal]
17)  Wielgosz MM, Rauch DA, Jones KS, Ruscetti FW, Ratner L.
Cholesterol dependence of HTLV-I infection.
AIDS Res Hum Retroviruses. 21: 43-50, 2005.
[Journal]
18)  Jones KS, Petrow-Sadowski C, Bertolette DC, Huang Y, Ruscetti FW.
Heparan sulfate proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells.
J Virol. 79: 12692-702, 2005.
[Journal]
19)  Jones KS, Akel S, Petrow-Sadowski C, Huang Y, Bertolette DC, Ruscetti FW.
Induction of human T cell leukemia virus type I receptors on quiescent naive T lymphocytes by TGF-beta.
J Immunol. 174: 4262-70, 2005.
[Journal]
20)  Nath MD, Ruscetti FW, Petrow-Sadowski C, Jones KS.
Regulation of the cell-surface expression of an HTLV-I binding protein in human T cells during immune activation.
Blood. 101: 3085-92, 2003.
[Journal]
21)  Seamon JA, Jones KS, Miller C, Roth MJ.
Inserting a nuclear targeting signal into a replication-competent Moloney murine leukemia virus affects viral export and is not sufficient for cell cycle-independent infection.
J Virol. 76: 8475-84, 2002.
[Journal]
22)  Jones KS, Nath M, Petrow-Sadowski C, Baines AC, Dambach M, Huang Y, Ruscetti FW.
Similar regulation of cell surface human T-cell leukemia virus type 1 (HTLV-1) surface binding proteins in cells highly and poorly transduced by HTLV-1-pseudotyped virions.
J Virol. 76: 12723-34, 2002.
[Journal]
Click Here to View Collapsed Bibliography.

This page was last updated on 4/9/2014.